![Paul Spence](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Spence
Corporate Officer/Principal bei
HALOZYME THERAPEUTICS, INC.
Profil
Mr. Paul Spence is a Chief Commercial Officer at Halozyme Therapeutics, Inc. Mr. Spence was previously employed as a Chief Commercial Officer by OptiNose, Inc., a Senior VP & Chief Commercial Officer-US by Aimmune Therapeutics, Inc., a Vice President-US Commercial by Nestle Health Science SA, and an Executive Director-Go to Market Models by Boehringer Ingelheim Pharmaceuticals, Inc. He received his undergraduate degree from The Pennsylvania State University and an MBA from Villanova University.
Aktive Positionen von Paul Spence
| Unternehmen | Position | Beginn |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2025 |
Ehemalige bekannte Positionen von Paul Spence
| Unternehmen | Position | Ende |
|---|---|---|
| OPTINOSEPAR | Corporate Officer/Principal | 21.05.2025 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2022 |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Corporate Officer/Principal | 01.01.2019 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01.06.2016 |
Ausbildung von Paul Spence
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
